Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China
· Delayed Price · Currency is CNY 18.42
-0.49 (-2.59%)
Apr 29, 2026, 3:04 PM CST
SHE:002317 Revenue
Guangdong Zhongsheng Pharmaceutical had revenue of 624.24M CNY in the quarter ending March 31, 2026, a decrease of -1.58%. This brings the company's revenue in the last twelve months to 2.51B, up 2.12% year-over-year. In the year 2025, Guangdong Zhongsheng Pharmaceutical had annual revenue of 2.52B with 2.24% growth.
Revenue (ttm)
2.51B
Revenue Growth
+2.12%
P/S Ratio
6.37
Revenue / Employee
1.42M
Employees
1,775
Market Cap
16.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.52B | 55.32M | 2.24% |
| Dec 31, 2024 | 2.47B | -143.13M | -5.48% |
| Dec 31, 2023 | 2.61B | -65.60M | -2.45% |
| Jan 1, 2023 | 2.68B | 247.06M | 10.17% |
| Jan 1, 2022 | 2.43B | 533.27M | 28.13% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Kangtai Biological Products | 2.66B |
| Shanghai Haoyuan Chemexpress | 2.88B |
| Nanjing King-Friend Biochemical Pharmaceutical | 3.76B |
| Fujian Cosunter Pharmaceutical | 430.98M |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 4.07B |
| ApicHope Pharmaceutical Group | 940.78M |
| Shandong Buchang Pharmaceuticals | 10.96B |
| Shenzhen Hepalink Pharmaceutical Group | 5.48B |